Last update 01 Nov 2024
Jiangsu Kangrun Biotechnology Co Ltd.
Last update 01 Nov 2024
Overview
Tags
Infectious Diseases
Respiratory Diseases
Other Diseases
Prophylactic vaccine
Vaccine
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
No Data
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
评价不同剂量四价流感病毒裂解疫苗在6-35月龄人群中接种的安全性和免疫原性的随机、双盲、同类疫苗对照的Ⅰ期临床试验
[Translation] A randomized, double-blind, similar vaccine-controlled phase I clinical trial to evaluate the safety and immunogenicity of different doses of quadrivalent influenza virus split vaccine in people aged 6-35 months
随机、双盲、阳性对照评价四价流感病毒裂解疫苗在3岁及以上人群中接种的免疫原性和安全性的Ⅲ期临床试验
[Translation] A randomized, double-blind, positive-controlled phase III clinical trial to evaluate the immunogenicity and safety of quadrivalent influenza virus split vaccine in people aged 3 years and above
评价冻干人用狂犬病疫苗（Vero 细胞）5 剂免疫程序和 4 剂免疫程 序（首针 2 剂）在 10 岁～50 岁健康人群中免疫持久性的随机、开 放、同类疫苗平行对照Ⅲ期临床补充研究。
[Translation] A randomized, open-label, parallel-controlled Phase III clinical supplementary study of the same vaccine was conducted to evaluate the immune persistence of a 5-dose immunization schedule and a 4-dose immunization schedule (2 doses for the first injection) of freeze-dried human rabies vaccine (Vero cells) in healthy people aged 10 to 50 years.
100 Clinical Results associated with Jiangsu Kangrun Biotechnology Co Ltd.
Login to view more data
Login to view more data
100 Deals associated with Jiangsu Kangrun Biotechnology Co Ltd.
Login to view more data
100 Translational Medicine associated with Jiangsu Kangrun Biotechnology Co Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 29 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
6
1
NDA/BLA
Approved
2
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free